MoneyWorks4Me

Vivanza Biosciences - Quaterly Results

08 Aug 2026 Evaluate
The June 2026 quarter revenue stood at Rs. 91.41 millions, up 16.88% as compared to Rs. 78.21 millions during the corresponding quarter last year.The company almost doubled its revenue to Rs. 1.45 millions  from Rs. 0.18 millions in the quarter ended June 2026.Operating Profit saw a handsome growth to 2.92 millions from 0.98 millions in the quarter ended June 2026.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 91.41 78.21 16.88 91.41 78.21 16.88 1122.31 29.43 3713.49
Other Income 3.73 0.17 2094.12 3.73 0.17 2094.12 1.09 0.35 211.43
PBIDT 2.92 0.98 197.96 2.92 0.98 197.96 8.17 -3.29 -348.33
Interest 1.06 0.77 37.66 1.06 0.77 37.66 2.79 3.51 -20.51
PBDT 1.86 0.21 785.71 1.86 0.21 785.71 5.38 -6.80 -179.12
Depreciation 0.05 0.03 66.67 0.05 0.03 66.67 0.22 0.14 57.14
PBT 1.81 0.18 905.56 1.81 0.18 905.56 5.16 -6.94 -174.35
TAX 0.36 0.00 0.00 0.36 0.00 0.00 1.43 0.01 14200.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00
PAT 1.45 0.18 705.56 1.45 0.18 705.56 3.73 -6.95 -153.67
Equity 40.00 40.00 0.00 40.00 40.00 0.00 40.00 40.00 0.00
PBIDTM(%) 3.19 1.25 154.94 3.19 1.25 154.94 0.73 -11.18 -106.51
Peers